Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
In a paradigm shift toward comprehensive animal care, government and non-government initiatives are emerging as pivotal catalysts for the growth of the global veterinary pain management market. These strategic efforts, aimed at enhancing awareness, education, and infrastructure development, are shaping a more compassionate and advanced landscape for animal healthcare. Two notable examples illustrate how these initiatives are poised to positively impact the veterinary pain management market.
In October 2020, the Federation of European Companion Animal Veterinary (FECAVA) took a significant step by launching a campaign titled "FECAVA Basic Practices in Anesthesia and Analgesia." This campaign is designed to spread crucial knowledge throughout Europe, encompassing important lectures scheduled for the coming years. Additionally, the initiative includes a series of six ready-to-use, printable posters and infographics focused on anesthesia and pain management in animals. This concerted effort not only promotes education and awareness among veterinary professionals but also signifies a commitment to elevating the standard practices in anesthesia and analgesia, fostering a culture of humane and effective pain management in companion animals across the continent.
Similarly, the Government of India's Department of Animal Husbandry and Dairying has taken proactive measures to bolster the animal husbandry and dairying sectors across the country. Initiatives such as the National Livestock Mission (NLM) and the Animal Husbandry Infrastructure Development Fund (AHIDF) underscore the government's commitment to promoting and developing these crucial sectors. By implementing these initiatives, the government aims to augment the efforts of states and union territories, fostering growth, sustainability, and modernization in the animal husbandry and dairying domains.
The National Livestock Mission (NLM) focuses on sustainable development and promotion of livestock, including veterinary services. By providing support for veterinary care and infrastructure, NLM contributes to the overall improvement of animal health and well-being. On the other hand, the Animal Husbandry Infrastructure Development Fund (AHIDF) aims to enhance infrastructure in the sector, promoting advanced facilities for veterinary care and management.
These government initiatives are not only commendable in their efforts to elevate the standards of animal care but also hold immense potential for market players in the global veterinary pain management market. As awareness increases and infrastructural development takes place, the demand for advanced pain management solutions is likely to surge. Veterinary professionals and caregivers, supported by government-backed campaigns and initiatives, are expected to seek innovative and effective pain management options for animals under their care.
The positive impact of government measures extends beyond the veterinary clinics and hospitals; it resonates with the broader theme of responsible animal care and welfare. As societies become more attuned to the needs of their animal companions, there is a growing expectation for ethical and advanced practices in veterinary care. This shift in perspective aligns with the goals of the veterinary pain management market, which seeks to provide solutions that enhance the quality of life for animals while ensuring the well-being of pets, livestock, and other companion animals.
In conclusion, government and non-government activities are emerging as powerful drivers in shaping the trajectory of the global veterinary pain management market. Initiatives such as the FECAVA campaign in Europe and the strategic efforts by the Government of India highlight a growing commitment to advancing animal healthcare practices. These endeavors are expected to create new opportunities for market players, fostering innovation, education, and a heightened emphasis on humane and effective pain management in the diverse landscape of veterinary care. As governments worldwide recognize the importance of animal welfare, the veterinary pain management market is well-positioned to thrive, creating a ripple effect that benefits both animals and the stakeholders contributing to their well-being.
Covered Aspects:
| Report Attribute/Metric | Details |
|---|---|
| Market Opportunities | Growing Exploration of Untapped Markets to Create Growth Avenues for the Key Players |
| Market Dynamics | Increasing illness incidence Knowledge of research and development Increasing financial support for healthcare facilities |
Veterinary Pain Management Market Highlights:
Global Veterinary Pain Management Market Overview
Global Veterinary Pain Management market size was valued at USD 1.99 billion in 2023.
The Veterinary Pain Management industry is projected to grow from USD 2.11 Billion in 2024 to USD 3.70 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.42% during the forecast period (2024 - 2032).
Growing prevalence of painful and inflammatory diseases in animals and rise in companion animal ownership and large pet population are driving market growth.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Veterinary Pain Management Market Trends
-
Rise in Companion Animal Ownership & Large Pet Population Boosted the Market Growth
The rise in companion animal ownership & large livestock population, rise in pet insurance with a surge in animal health expenditure, and growing prevalence of animal diseases are expected to drive the growth of the global veterinary pain management market.
The rising number of pet owners across the globe is expected to support market growth over the forecast period. For instance, according to the American Society for the Prevention of Cruelty to Animals (ASPCA), around 6.5 million companion animals enter the US animal shelters nationwide each year. Moreover, as stated by the American Pet Products Association 2015 to 2016 (APPA) survey, approximately 44% of all households in the US had a dog, and 35% had a cat.
Veterinary Pain Management Market Segment Insights
Veterinary Pain Management Product Insights
The global veterinary pain management market segmentation, based on product, includes medications, and devices. The market, based on medications, has been sub-segmented into nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, local anesthetics, and others. The NSAIDs segment has been further segmented into meloxicam, etodolac, and others. The medications product has held the majority share in 2022 in the global Veterinary Pain Management market revenue. This is due to the product launches and large preference by veterinary practitioners.
August 2020: Elanco (US) has acquired the firm Bayer Animal Health (Germany). The acquisition, will broaden Elanco's scope and capabilities and position the business to become a leader in the lucrative, long-lasting animal health sector
Veterinary Pain Management Application Insights
The global veterinary pain management market segmentation is based on an application that includes joint pain, postoperative pain, cancer, and others. The joint pain has dominated the market in 2022 and is projected to be the fastest-growing segment during the forecast period, 2024-2032.This is due to large population of osteoarthritis and new product launches are expected to boost the growth of the market during the forecast period.
June 2019: Ceva (US) had increased its investments in Mainland France, notably in Laval, where it has created its worldwide hub for companion animal innovation. This addition of an innovative hub is continuously supporting the company's efforts to develop innovative products for animals
Veterinary Pain Management Animal Type Insights
The global veterinary pain management market segmentation is based on an animal type that includes companion animals and livestock animals. Companion animals have been further segmented into dogs, cats, horses, and others. The market, on the basis of livestock animals, has been further divided into cattle, pigs, poultry, and others. Companion animals has held the majority share in 2022 in the global veterinary pain management market revenue. This is due to the increasing incidence rate of zoonotic diseases and growing pet insurance.
Figure 2: Global Veterinary Pain Management Market Size, By Animal Type, 2023 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
Veterinary Pain Management Distribution Channel Insights
The global veterinary pain management market segmentation is based on a distribution channel that includes veterinary hospitals & clinics, pharmacies, and online pharmacies. Veterinary hospitals & clinics has dominated the market in 2022 and is projected to be the fastest-growing segment during the forecast period, 2024-2032. This is due to the wide availability of pain medications in these settings.
Veterinary Pain Management Regional Insights
By Region, the study segments the market into North America, Europe, Asia-Pacific, and the Rest of the World. The North America clear aligners market accounted for the largest market share in 2022. This is due to the increasing pet population and the rising number of neurological diseases in the region. Furthermore, the presence of a large number of noticeable players such as Zoetis (New Jersey, US), Merck & Co., Inc. (New Jersey, US), and Assisi Animal Health (New Mexico, US) in this region is the major driving factor of the market in the North America.
Further, the major countries studied are the U.S., Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3: Global Veterinary Pain Management Market Size, By Region 2023 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
Europe Veterinary Pain Management market accounts for the second-largest market share due to the rising prevalence of transmissible animal diseases and increased focus on the health & well-being of animals is driving the demand for pain management products further, UK Veterinary Pain Management market was attributed to hold the largest market share, and the France Veterinary Pain Management market is expected to fastest-growing market in the European region.
The Asia-Pacific Veterinary Pain Management market is expected to grow at a significant share from 2023 to 2032. This is due to the presence of rapidly developing economies of China, India, and South Korea. The region provides many opportunities for market players to grow. The increased pet adoptions and growth in the population of companion animals is expected to drive the market growth.
Moreover, China Veterinary Pain Management market is expected to hold the largest market share, and India Veterinary Pain Management market is expected fastest-growing market in the Asia-Pacific region.
The Rest of the World is segmented into the Middle East, Africa, and Latin America. Veterinary Pain Management market in the above-mentioned regions is likely to witness growth due to the presence of countries such as Egypt and Saudi Arabia. The Middle East & Africa region has less economic developments and extremely low-income due to which the region accounts for the least market share but is expected to grow with the to improving veterinary healthcare facilities and expansion of the middle-class population in these regions.
Veterinary Pain Management Key Market Players & Competitive Insights
The global veterinary pain management market is characterized by the presence of many global, regional, and local vendors. Developments in the healthcare industry and growing research and development make the veterinary pain management market lucrative. To expand their reach and optimize their operational costs, the major players focus on obtaining regulatory authorizations from government agencies for their products and emphasize acquisitions and product launches to gain a substantial market share. The market comprises tier-1, tier-2, and local players.
The tier-1 and tier-2 players have reached across the globe with diverse product portfolios. Companies such as Boehringer Ingelheim (Ingelheim am Rhein, Germany), Vetoquinol (Lure, France), Ceva Animal Health, LLC (Libourne, France), Chanelle Pharma (Galway, Ireland), Elanco (Indiana, US) dominate the global veterinary pain management market due to product differentiation, financial stability, strategic developments, and diversified regional presence. The players are focused on investing in research and development.
Furthermore, they adopt strategic growth initiatives, such as expansion, product launches, joint ventures, and partnerships, to strengthen their market position and capture a large customer base. One of the primary business strategies adopted by manufacturers in the global veterinary pain management industry to benefit clients and expand the clear aligners market sector is to manufacture locally to reduce operating costs.
Zoetis Animal Healthcare has more than 65 years of experience in delivering medicines, vaccines and diagnostics products along with complemented by biodevices, genetic tests and precision livestock farming. The company has more than 65 years of experience in animal healthcare. The company has approximately 300 number of product lines. The company serves veterinarians, livestock producers and people who raise and care for farm and companion animals in more than 100 countries.
The company offers various products and services for various species including cattle, cats, dogs, fish, horses, pigs, poultry, and sheep. For instance, In May 2023, Zoetis (US) announced FDA approval for its product “Librela (bedinvetmab injection)”. This product is used for osteoarthritis pain relieve in dogs.
Veterinary pain management is expected to decline during the Covid-19 pandemic as veterinary visits are limited. Therefore, the animal healthcare approach has been changed and care for emergency cases and critically ill animals is provided. Thus, this is expected to lead to stabilization in the veterinary pain management market in the forecast period.
Key Companies in the Veterinary Pain Management Market Include
- Boehringer Ingelheim (Ingelheim am Rhein, Germany)
- Vetoquinol (Lure, France)
- Ceva Animal Health, LLC (Libourne, France)
- Chanelle Pharma (Galway, Ireland)
- Elanco (Indiana, US)
- Dechra Pharmaceuticals PLC (Northwich, UK)
- Zoetis (New Jersey, US)
- Merck & Co., Inc. (New Jersey, US)
- Assisi Animal Health(New Mexico, US)
- Eltech K-Laser (Treviso, Italy)
Veterinary Pain Management Industry Developments
January 2022: Zoetis (US) received FDA approval for its product Solensia (frunevetmab injection). This product is used for osteoarthritis pain reliving in cat.
January 2022: Elanco's (US) received US Food and Drug Administration (FDA) approved Zorbium (buprenorphine transdermal solution) for Cats. With this approval, the business is able to better serve veterinary practices and increase its pain management options. Additionally, ZORBIUM is a cutting-edge, transdermal formulation of a widely used opioid (buprenorphine) in cats that enables veterinarians to provide pain relief consistently and reliably to their post-operative feline patients.
May 2021: Chanelle Pharma (Ireland) expanded its distribution and manufacturing operations to Ballinasloe. Through this expansion, Chanelle Pharma will transform the current Chanelle Pet location in Loughrea into a new 35,000 square foot production plant with a goal of creating 60 employments in Ballinasloe the next five years.
Veterinary Pain Management Market Segmentation
Veterinary Pain Management Product Outlook
- Medication
- Nonsteroidal anti-inflammatory drugs (NSAIDs)
- Meloxicam
- Etodolac
- Others
- Opioids
- Local Anesthetics
- Others
- Nonsteroidal anti-inflammatory drugs (NSAIDs)
- Devices
- Laser Therapy Devices
- Electromagnetic Therapy Devices
Veterinary Pain Management Animal Type Outlook
- Companion Animals
- Dogs
- Cats
- Horses
- Others
- Livestock Animals
- Cattle
- Pigs
- Poultry
- Others
Veterinary Pain Management Application Outlook
- Joint Pain
- Postoperative Pain
- Cancer
- Others
Veterinary Pain Management Distribution Channel Outlook
- Veterinary Hospitals & Clinics
- Pharmacies
- Online Pharmacies
Veterinary Pain Management Regional Outlook
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Rest of the World
- Middle East
- Africa
- Latin America
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
